載入...
CKS2 and RMI2 are two prognostic biomarkers of lung adenocarcinoma
BACKGROUND: Lung adenocarcinoma (ACA) is the most common subtype of non-small-cell lung cancer. About 70%–80% patients are diagnosed at an advanced stage; therefore, the survival rate is poor. It is urgent to discover accurate markers that can differentiate the late stages of lung ACA from the early...
Na minha lista:
| 發表在: | PeerJ |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
PeerJ Inc.
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7547618/ https://ncbi.nlm.nih.gov/pubmed/33083148 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7717/peerj.10126 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|